Maikel Peppelenbosch will use PRECISE-PANC to develop biomarkers that aid in the early detection of pancreatic cancer, enabling timely intervention before invasive cancer develops. It holds potential to revolutionize pancreatic cancer screening, reduce unnecessary surgery, and save lives.